Initial characterisation of ELISA assays and the immune response of the clinically correlated SARS-CoV-2 biobank SERO-BL-COVID-19 collected during the pandemic onset in Switzerland
Kaltenbach, H.-M.; Rudolf, F.; Linnik, J.; Deichmann, J.; Ruf, T.; Altamura, R.; Kapetanovic, E.; Mason, D.; Wagner, B.; Goetz, T.; Mundorff, L.; Stoll-Rudin, K.; Krebs, C.; Renz, T.; Hochueli, T.; Haymoz, S.; Hosch, M.; Periat, N.; Richert, M.; Sesia, S.; Paris, D.; Quinto, C. B.; Probst-Hensch, N.; Niederhauser, C.; Reddy, S.; Nickel, B.; Savic, M.
Show abstract
BackgroundTo accurately measure seroprevalance in the population, both the expected immune response as well as the assay performances have to be well characterised. Here, we describe the collection and initial characterisation of a blood and saliva biobank obtained after the initial peak of the SARS-CoV-2 pandemic in Switzerland. MethodsTwo laboratory ELISAs measuring IgA & IgG (Euroimmun), and IgM & IgG (Epitope Diagnostics) were used to characterise the biobank collected from 349 re- and convalescent patients from the canton of Basel-Landschaft. FindingsThe antibody response in terms of recognized epitopes is diverse, especially in oligosymptomatic patients, while the average strength of the antibody response of the population does correlate with the severity of the disease at each time point. InterpretationThe diverse immune response presents a challenge when conducting epidemiological studies as the used assays only detect[~] 90% of the oligosymptomatic cases. This problem cannot be rectified by using more sensitive assay setting as they concomitantly reduce specificity. FundingFunding was obtained from the "Amt fur Gesundheit" of the canton Basel-Landschaft, Switzerland.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- SARS-CoV-2 antibody testing in a UK population: detectable IgG for up to 20 weeks post infection 93%
- The Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland (Study protocol) 91%
- Antibody response in individuals affected with Sars-Cov-2 infection: temporal trends and qualitative and quantitative differences in symptomatic and asymptomatic subjects. A Cross Sectional Analysis. Ab-Covid Study 91%
Similar papers in this journal
- Antibody seroprevalence and rate of asymptomatic infections with SARS-CoV-2 in Austrian hospital personnel 92%
- High Seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers 91%
- Low Seroprevalence of SARS-CoV-2 in Rhode Island Blood Donors Determined using Multiple Serological Assay Formats 91%
Similar papers in this journal
- A multiplex serological assay for the characterization of IgG immune response to SARS-CoV-2 93%
- A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects 93%
- Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021 93%
Similar papers in this journal
- Serological assessment of SARS-CoV-2 exposure in northern Sweden by the use of at-home sampling to meet geographical challenges in rural regions 92%
- Comparative sensitivity evaluation for 122 CE-marked SARS-CoV-2 antigen rapid tests 90%
- Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period 90%
Similar papers in this journal
- Kinetics and seroprevalence of SARS-CoV-2 antibodies – a comparison of 3 different assays 93%
- A serological assay to detect SARS-CoV-2 antibodies in at-home collected finger-prick dried blood spots 92%
- Detection of neutralizing antibodies against SARS-CoV-2 by using a commercial surrogate virus neutralization ELISA: can it substitute the classical neutralization test? 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.